Jose Rubio

2 presentations

• INCORPORATING NOVEL MUSCARINIC AGENTS FOR SCHIZOPHRENIA INTO CLINICAL PRACTICE: OVERCOMING CLINICAL INERTIA

  2026 ASCP Annual Meeting

• T96. REAL-WORLD USE OF XANOMELINE AND TROSPIUM CHLORIDE IN SCHIZOPHRENIA: PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND OUTCOMES

  2026 ASCP Annual Meeting